Nan has had a massive run here with the market just starting to understand the printer cartridge model is the key to profitability.
On the coal face I see the traceability being a big positive over tristel wipe locally and strong preference by staff to use the trophon over manual wipes. Despite the guidelines I seen nearly universal non compliance with HLD for semicritical use ie ultrasound guided invasive procedure cvc etc.
You can have evidence and guidelines but culturally local health authorities and individuals can just ignore it. Nan may need to ramp up marketing in continental europe and japan to start getting some traction. The message about semicritical use is still not out there even locally.
Nan has had a massive run here with the market just starting to...
Add NAN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.75 |
Change
-0.010(0.36%) |
Mkt cap ! $833.1M | |||
| Open | High | Low | Value | Volume |
| $2.73 | $2.76 | $2.71 | $1.479M | 541.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 2044 | $2.74 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.76 | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.76 |
Change
-0.010 ( 0.41 %) |
||||
| Open | High | Low | Volume | ||
| $2.72 | $2.76 | $2.71 | 172952 | ||
| Last updated 15.59pm 26/04/2024 ? | |||||
| NAN (ASX) Chart |